{
    "Trade/Device Name(s)": [
        "IMMULITE\u00ae IGF Control Module",
        "IMMULITE\u00ae Gastrin Control Module"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K150132",
    "Predicate Device Reference 510(k) Number(s)": [
        "K955440"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "January 19, 2015",
    "Summary Letter Received Date": "January 21, 2015",
    "Submission Date": "March 2, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "IGF-I",
        "IGFBP-3",
        "Gastrin"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IMMULITE",
        "IMMULITE 1000",
        "IMMULITE 2000"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for IMMULITE IGF and Gastrin Control Modules as assayed, bi-level controls for monitoring performance of respective IMMULITE assays.",
    "Indications for Use Summary": "Assayed, bi-level controls intended for use with IMMULITE IGF-I, IGFBP-3, and Gastrin assays as aids in monitoring day-to-day assay performance.",
    "fda_folder": "Clinical Chemistry"
}